International Reports of Unexpected Low Plasma Concentrations of Dabigatran Suggest That More Frequent Measurements Will Add Value

Ruth L. Savage; Marilina Castellano; Michael V. Tatley

doi:10.1055/s-0037-1603361

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2017; 43(06): 635-638
DOI: 10.1055/s-0037-1603361

Letter to the Editor

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

International Reports of Unexpected Low Plasma Concentrations of Dabigatran Suggest That More Frequent Measurements Will Add Value

Ruth L. Savage

¹WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre, Uppsala, Sweden

²New Zealand Pharmacovigilance Centre, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand

³Department of General Practice, University of Otago, Christchurch, New Zealand

,

Marilina Castellano

¹WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre, Uppsala, Sweden

,

Michael V. Tatley

²New Zealand Pharmacovigilance Centre, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand

References
1 Chin PKL. Which patients may benefit from dose adjustment of non-vitamin K antagonist oral anticoagulants?. Semin Thromb Hemost 2015; 41 (02) 195-207
2 Lindquist M. VigiBase, the WHO Global ICSR Database System: basic facts. Drug Inf J 2008; 42: 409-419
3 Castellano M, Sartori D, Savage R. Dabigatran and thromboembolism: analysis of case histories for risk factors. WHO Pharmaceuticals Newletter 2016; 3: 15-22
4 Boehringer Ingelheim. Management of bleeding in emergency situations for patients treated with Pradaxa (dabigatran etexilate). January 2015. Available at: http://products.boehringer-ingelheim.com/pradaxa/sites/default/files/Bleeding_management.pdf . Accessed February 17, 2017
5 Breuer L, Ringwald J, Schwab S, Köhrmann M. Ischemic stroke in an obese patient receiving dabigatran [letter]. N Engl J Med 2013; 368 (25) 2440-2442
6 Douros A, Schlemm L, Bolbrinker J, Ebinger M, Kreutz R. Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome [letter]. Thromb Haemost 2014; 112 (02) 419-420
7 Sargento-Freitas J, Silva F, Pego J, Duque C, Cordeiro G, Cunha L. Cardioembolic stroke in a patient taking dabigatran etexilate: the first case report of clinical and pharmacologic resistance [letter]. J Neurol Sci 2014; 346 (1–2): 348-349
8 Lee D, DeFilipp Z, Judson K, Kennedy M. Subtherapeutic anticoagulation with dabigatran following Roux-en-Y bypass surgery [letter]. J Cardiol Cases 2013; 8: e49-e50
9 Chin PKL, Wright DFB, Doogue MP, Begg EJ. Learning more from the dabigatran concentrations in the RE-LY study. J Am Coll Cardiol 2014; 63 (24) 2746-2747